These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17047598)

  • 41. I(f) current and heart rate control.
    César LA
    Arq Bras Cardiol; 2007 Apr; 88(4):e99-e102. PubMed ID: 17546262
    [No Abstract]   [Full Text] [Related]  

  • 42. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N; Bhargava B
    Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ivabradine: recent and potential applications in clinical practice.
    Riccioni G
    Expert Opin Pharmacother; 2011 Feb; 12(3):443-50. PubMed ID: 21254949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ranolazine and Ivabradine: two different modalities to act against ischemic heart disease.
    Cacciapuoti F
    Ther Adv Cardiovasc Dis; 2016 Apr; 10(2):98-102. PubMed ID: 26944071
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
    Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
    Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Heart rate reduction as a therapeutic strategy: novel options].
    Hoppe UC
    Internist (Berl); 2006 Dec; 47(12):1289-93. PubMed ID: 17077980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A New Insight on Anti-Ischemic Action of Ivabradine in Patients With Stable Angina].
    Kobalava ZD; Shavarov AA; Kiyakbaev GK
    Kardiologiia; 2017 Mar; 57(3):68-74. PubMed ID: 28762939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
    Swedberg K; Komajda M; Böhm M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
    Lancet; 2010 Sep; 376(9744):875-85. PubMed ID: 20801500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Ivabradine--a medical alternative for patients with chronic stable angina pectoris].
    Haghfelt TH
    Ugeskr Laeger; 2006 Nov; 168(46):3991-3. PubMed ID: 17125651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Ivabradine, an I(f) current inhibitor--new treatment options in coronary heart disease].
    Mach F
    Rev Med Suisse; 2009 May; 5(205):1168-70, 1172-3. PubMed ID: 19517748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice.
    Koester R; Kaehler J; Ebelt H; Soeffker G; Werdan K; Meinertz T
    Clin Res Cardiol; 2010 Oct; 99(10):665-72. PubMed ID: 20454968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The biological effects of ivabradine in cardiovascular disease.
    Speranza L; Franceschelli S; Riccioni G
    Molecules; 2012 Apr; 17(5):4924-35. PubMed ID: 22547315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. I f inhibition with ivabradine : electrophysiological effects and safety.
    Savelieva I; Camm AJ
    Drug Saf; 2008; 31(2):95-107. PubMed ID: 18217787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antianginal efficacy of ivabradine in a very old patient with aortic stenosis: effects on cardiac output and transvalvular aortic gradients].
    Nervo E; Menditto E; Taglieri C; Lombardo E; Piccolo S; Feola M
    G Ital Cardiol (Rome); 2010 Sep; 11(9):699-702. PubMed ID: 21348187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heart rate lowering by inhibition of the pacemaker current: a new therapeutic perspective in cardiovascular disease.
    Dilaveris P; Giannopoulos G; Synetos A; Gatzoulis K; Stefanadis C
    Cardiovasc Hematol Agents Med Chem; 2006 Oct; 4(4):313-8. PubMed ID: 17073608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation.
    Cappato R; Castelvecchio S; Ricci C; Bianco E; Vitali-Serdoz L; Gnecchi-Ruscone T; Pittalis M; De Ambroggi L; Baruscotti M; Gaeta M; Furlanello F; Di Francesco D; Lupo PP
    J Am Coll Cardiol; 2012 Oct; 60(15):1323-9. PubMed ID: 22981555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Focus on ivabradine: a new heart rate-controlling drug.
    Riccioni G
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):107-13. PubMed ID: 19210206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina Pectoris.
    Borer JS; Swedberg K; Komajda M; Ford I; Tavazzi L; Böhm M; Depre C; Wu Y; Maya J; Dominjon F
    Cardiology; 2017; 136(2):138-144. PubMed ID: 27614723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study.
    Köster R; Kaehler J; Meinertz T;
    Am Heart J; 2009 Oct; 158(4):e51-7. PubMed ID: 19781403
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Heart rate as a cardiovascular risk factor: potential clinical benefit with ivabradine].
    Purcell H; Mach F
    Rev Med Suisse; 2007 May; 3(113):1375-8, 1381-2. PubMed ID: 17645051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.